A review of the literature on the relationships between genetic polymorphisms and chemotherapy-induced nausea and vomiting

Komal P. Singh, Anand A. Dhruva, Elena Flowers, Kord M. Kober, Christine Miaskowski

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Abstract

Despite current advances in antiemetic treatments, between 30% to and 60% of oncology patients experience chemotherapy-induced nausea (CIN) and 13% to 33% report chemotherapy-induced vomiting (CIV). Inter-individual differences are observed in the occurrence and severity of chemotherapy-induced nausea and vomiting (CINV). This review summarizes and critiques studies on associations between occurrence and severity of CINV and polymorphisms in serotonin receptor, drug metabolism, and drug transport pathway genes. Sixteen studies evaluated the associations between the occurrence and/or severity of CINV and single nucleotide polymorphisms (SNPs). Across these studies, three SNPs in 5-hydroxytryptamine receptor (5-HT3R) genes, two alleles of the cytochrome P450 family 2 subfamily D member 6 (CYP2D6) gene, and three SNPs in ATP binding cassette subfamily B member 1 (ABCB1) gene were associated with the occurrence and severity of CINV. Given the limited number of polymorphisms evaluated, additional research is warranted to identify new mechanisms to develop more targeted therapies.

Original languageEnglish (US)
Pages (from-to)51-61
Number of pages11
JournalCritical Reviews in Oncology/Hematology
Volume121
DOIs
StatePublished - Jan 2018
Externally publishedYes

Keywords

  • Antiemetics
  • Drug metabolism
  • Drug transport
  • Nausea
  • Serotonin
  • Vomiting

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'A review of the literature on the relationships between genetic polymorphisms and chemotherapy-induced nausea and vomiting'. Together they form a unique fingerprint.

Cite this